Federated Hermes
AQST icon

Federated Hermes’s Aquestive Therapeutics AQST Stock Holding History

Federated Hermes’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2M Buy
2,940,339
+907,517
+45% +$3.68M 0.02% 581
2025
Q4 		$13.1M Buy
2,032,822
+1,249,044
+159% +$7.78M 0.02% 552
2025
Q3 		$4.38M Buy
+783,778
New +$3.39M 0.01% 765
2024
Q2 		– Sell
-1,404
Closed -$5.98K – 2026
2024
Q1 		$5.98K Sell
1,404
-1,045
-43% -$3.48K ﹤0.01% 1820
2023
Q4 		$4.95K Buy
2,449
+204
+9% +$360 ﹤0.01% 1853
2023
Q3 		$3.44K Hold
2,245
– – ﹤0.01% 1922
2023
Q2 		$3.7K Buy
+2,245
New +$4.06K ﹤0.01% 1935
2020
Q4 		– Sell
-58
Closed -$1K – 2236
2020
Q3 		$1K Buy
+58
New +$379 ﹤0.01% 2134

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Federated Hermes's AQST Position: Q1 2026 in Review

Federated Hermes increased its Aquestive Therapeutics (AQST) stake by 45% in Q1 2026, buying an estimated $3.68M and bringing the position to 2,940,339 shares worth $12.2M. The position accounts for 0.02% of the portfolio, ranked #581.

Federated Hermes first reported a position in AQST in Q3 2020 and has held it in 8 quarters since. The position peaked at $13.1M in Q4 2025. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • Federated Hermes held 2,940,339 shares of Aquestive Therapeutics worth $12.2M as of Q1 2026.
  • Federated Hermes bought 907,517 Aquestive Therapeutics shares in Q1 2026, an estimated $3.68M.
  • Aquestive Therapeutics made up 0.02% of Federated Hermes's portfolio in Q1 2026, its #581 holding.
  • Federated Hermes first reported a position in Aquestive Therapeutics in Q3 2020 and has held it in 8 quarters since.
  • Federated Hermes's Aquestive Therapeutics position peaked at $13.1M in Q4 2025.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.